Clinical trial Recruiting at 7 sites Observational Ages 18 and up

Gastric preconditioning before esophagectomy for patients at high risk of anastomotic leak

Official title: Gastric Preconditioning by Percutaneous Angioembolization Before Esophagectomy in Patients With a High Risk of Anastomotic Leak

Run by Memorial Sloan Kettering Cancer Center · NCT07449208 · Data updated 2026-11-12

This registry will see if gastric preconditioning by percutaneous angioembolization before esophagectomy changes how often anastomotic leaks happen in people with esophageal cancer who are at high risk.

More Anastomotic Leak trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorMemorial Sloan Kettering Cancer Center
Academic / other
Locations7 sites (Basking Ridge, New Jersey and 6 other locations)
StatusRecruiting
StartedFebruary 25, 2026
Main results expectedFebruary 25, 2029
Study endsFebruary 25, 2029
Registry record updatedMarch 4, 2026
Trial IDNCT07449208 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People with pathologically confirmed esophageal cancer scheduled for esophagectomy who are at high risk for anastomotic leak (for example prior foregut/bariatric surgery, salvage esophagectomy, planned cervical anastomosis, or two or more specified comorbidities) and who agree to gastric preconditioning are ideal candidates.

Probably not a fit

Patients with low baseline leak risk, those not eligible for or who decline preconditioning, or those with contraindications to angioembolization are unlikely to gain benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry enrolls patients with pathologically confirmed esophageal cancer who are considered high risk for anastomotic leak and who are candidates for gastric preconditioning via percutaneous angioembolization prior to esophagectomy. Clinical teams will document baseline risk factors (for example prior foregut/bariatric surgery, salvage esophagectomy, planned cervical anastomosis, or multiple comorbidities), the use of preconditioning, surgical details, and postoperative outcomes including leak incidence. Data are collected across three Memorial Sloan Kettering locations in New Jersey and analyzed descriptively to characterize leak rates and related complications. No experimental therapies beyond standard-of-care preconditioning and esophagectomy are mandated by the registry.

Why it matters

Potential benefit: If successful, preconditioning could reduce anastomotic leaks after esophagectomy, leading to fewer complications and faster recovery.

How similar studies have gone: Related concepts of gastric or ischemic preconditioning have been explored with mixed results, and percutaneous angioembolization before esophagectomy remains relatively novel and not yet proven in large trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documentation of Disease

  * Patients must have pathologically confirmed esophageal malignancy requiring esophagectomy.
  * Patients must also have risk factors for anastomotic leak:
  * Previous foregut or bariatric surgery (gastric sleeve or gastric bypass), but excluding fundoplication-only surgery OR
  * Salvage esophagectomy OR
  * Planned cervical anastomosis OR
  * Two or more comorbidities:
  * Diabetes, obesity, coronary artery disease, vascular disease (including celiac stricture or atherosclerosis, significant aortic disease, or any previous diagnosis of peripheral arterial disease), steroid use, hypertension, current or former smoker, renal insufficiency, and heart failure.
* Definition of Disease

  * Patients must have pathologically confirmed esophageal malignancy requiring esophagectomy and risk factors for anastomotic leak, as described above.
  * Patients must be candidate and have agreed to receive gastric preconditioning procedure
* Prior Treatment

  o There are no requirements with regard to prior treatment.
* Age ≥ 18
* ECOG Performance Status of ≤ 2 (See Appendix I for performance status criteria)

Where it's running

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
    Basking Ridge, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Monmouth (All Protocol Activities)
    Middletown, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Bergen (All Protocol Activities)
    Montvale, New Jersey, United States
    Recruiting
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
    Commack, New York, United States
    Recruiting
  • Memorial Sloan Kettering Westchester (All protocol activities)
    Harrison, New York, United States
    Recruiting
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    New York, New York, United States
    Recruiting
Show 1 more location
  • Memorial Sloan Kettering Nassau (All Protocol Activities)
    Rockville Centre, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Daniela Molena, MD — Memorial Sloan Kettering Cancer Center
  • Study coordinator: Daniela Molena, MD
  • Email: molenad@mskcc.org
  • Phone: 212-639-3870

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.